Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass
- PMID: 38404816
- PMCID: PMC10884443
- DOI: 10.1016/j.heliyon.2024.e25739
Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass
Abstract
Background: Sarcopenia frequently complicates cirrhosis and leads to substantial mortality. Infection is a complication of cirrhosis that results in high mortality. Both sarcopenia and infection are accompanied by systemic inflammation and adversely affect the prognosis of cirrhosis. This article was designed to decipher the association of sarcopenia with infection occurrence, and to ascertain the risk factors for the 90-day death rate in hospitalized cirrhotic patients with infection.
Methods: A total of 808 cirrhotic patients (373 with infection and 435 without) who had undergone abdominal CT from 2017 to 2021 were recruited for this retrospective single-center research. The skeletal muscle index was assessed at the level of the third lumbar vertebra (L3 SMI). The optimal cutoff value of the CAIL3 model (CTP score, AKI, INR, and L3 SMI) for the prediction of the 90-day death rate was authenticated with receiver operating characteristic (ROC) analysis.
Results: L3 SMI was considered to be the independent risk factor for infection in cirrhotic patients and 90-day death rate in these patients with infection (HR 2.840 95% CI 2.076-3.886, p < 0.001 for infection and HR 2.097 95% CI 1.142-3.850, p = 0.017 for 90-day death rate, respectively). CAIL3 had an area under the ROC curve of 0.840, and a cutoff value of 0.21 for predicting the poor outcome (sensitivity 77.22% and specificity 76.53%, respectively).
Conclusion: L3 SMI is an essential factor associated with infection and 90-day death rate in cirrhotic patients. CAIL3 may be a novel model for the prediction of the 90-day death risk in cirrhotic patients with infections.
Keywords: Infection; Liver cirrhosis; Mortality; Predictive model; Sarcopenia; Skeletal muscle index.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.J Magn Reson Imaging. 2023 Nov;58(5):1569-1578. doi: 10.1002/jmri.28690. Epub 2023 Mar 17. J Magn Reson Imaging. 2023. PMID: 36932680
-
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1948-1958. doi: 10.1002/jcsm.12797. Epub 2021 Sep 14. J Cachexia Sarcopenia Muscle. 2021. PMID: 34520115 Free PMC article.
-
Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.Clin Mol Hepatol. 2018 Sep;24(3):319-330. doi: 10.3350/cmh.2017.0077. Epub 2018 Apr 30. Clin Mol Hepatol. 2018. PMID: 29706058 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis.J Hepatol. 2022 Mar;76(3):588-599. doi: 10.1016/j.jhep.2021.11.006. Epub 2021 Nov 14. J Hepatol. 2022. PMID: 34785325
References
LinkOut - more resources
Full Text Sources